Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobetasol Propionate for Post-Cataract Surgery Inflammation (CLOSE-2)
NCT04249076Phase 3Completed
- Sponsor
- Laboratorios Salvat
- Start
- Jun 2020
- Primary completion
- Apr 2021
- Modality
- Nanoparticles, Implantable Devices, Hydrogel Systems
- Countries
- 1
01
Overview
A Phase 3 trial of GPN00833 in post-operative inflammation, postoperative pain, sponsored by Laboratorios Salvat. Started Jun 2020; status: completed.
02
Drugs
GPN00833
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT04249076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04249076.